Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the treatment of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://matteohccv763896.canariblogs.com/retaglutide-a-promising-glp-1-receptor-agonist-53781928